Sterilization

• US 6,521,179 B1
• Filed: 08/09/2000
• Issued: 02/18/2003
• Est. Priority Date: 08/11/1999
• Status: Expired due to Term

• Current Assignee: Biomedical Design, Inc.
• Original Assignee: Biomedical Design, Inc.
• Inventors: Girardot, Marie-Nadia, Girardot, Jean-Marie
• Primary Examiner(s): Warden, Sr., Robert J.
• Assistant Examiner(s): Chorbaji, Monzer R.
• Application Number:
  US09/635,295
• Time in Patent Office: 923 Days
• Field of Search: 422/1, 422/28-29, 422/34-36, 422/40, 422/256, 422/292, 422/307, 422/901, 530/356, 530/402, 435/1.1, 623/2, 623/11, 623/901, 623/66, 623/915, 623/920
• US Class Current: 422/28
• CPC Class Codes: A01N 1/00 Preservation of bodies of humans or animals, or parts thereof
• CPC Class Codes: A61L 2/0088 Liquid substances
• CPC Class Codes: A61L 27/3687 characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
• CPC Class Codes: A61L 27/3691 characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
• CPC Class Codes: Y10S 623/915 Method or apparatus for preparing biological material
• CPC Class Codes: Y10S 623/92 Method or apparatus for preparing or treating prosthetic

Abstract

Allograft tissue prostheses, as well as tissue valves for replacement of defective heart valves and other tissue-engineered products (TEPs), are effectively sterilized by treatment with a coupling agent known to create amide linkages between amines and carboxylic acids in the presence of a protecting agent. The sterilization treatment preferably employs EDC as a water-soluble coupling agent, plus a water-soluble protecting agent which complexes with potentially reactive amine or carboxyl moieties on the biological tissue, in the optional presence of isopropanol or an equivalent alkanol. One preferred sterilization treatment process uses a buffered aqueous solution where a hydroxymonoamine buffer, such as TRIS plus ethanolamine, provides both the buffering effect and the protecting agents, effectively complexing with potentially reactive carboxyl moieties on the tissue. The treatment is particularly advantageous for sterilizing fresh biological tissue where substantial cross-linking that would alter physical properties of the tissue is undesirable or any tissues or TEPs where a controllable amount of cross-linking is desired.

Claims

1. A process for sterilization of biological tissue material, which process comprises

treating such material with an aqueous solution containing

(a) an amount of a water-soluble coupling agent capable of creating amide bonds that is effective to achieve sterilization and

(b) an amount of a protecting agent which is effective to complex with potentially reactive amine or carboxyl moieties on the biological tissue material so as to deter such complexed moieties from taking part in an amide-forming cross-linking reaction and thereby limit the amount of cross-linking, and

maintaining such treatment for a time and at a temperature which is sufficient to achieve penetration of said coupling agent into the cells of microorganisms carried by such material and effectively kill such microorganisms.

2. The process for sterilization according to claim 1 wherein said coupling agent is present in said solution at a concentration of at least about 25 mM.

3. The process for sterilization according to claim 2 wherein said treatment is carried out at a temperature of about 25°

to about 55°

C. in the presence of an effective amount of a lower alkanol.

4. The process for sterilization according to claim 2 wherein said treatment is carried out at a temperature of at least about 35°

C. in the absence of any effective amount of a lower alkanol and said treatment is carried out for at least about 24 hours.

5. The process for sterilization according to claim 2 wherein said protecting agent is present in said aqueous solution at a concentration of at least about 25 mM.

6. The process for sterilization according to claim 5 wherein said protecting agent includes a monoamine.

7. The process for sterilization according to claim 5 wherein said protecting agent includes a monocarboxylic acid.

8. The process for sterilization according to claim 1 wherein said coupling agent is present in said solution at a concentration of at least about 35 mM and said protecting agent is present at a concentration between about 50 and about 150 mM.

9. The process for sterilization according to claim 8 wherein said treatment is carried out for at least about 6 hours.

10. The process for sterilization according to claim 1 wherein said coupling agent is EDC which is present at a concentration of at least about 50 millimolar and said treatment is carried out for at least about 10 hours at a temperature of at least about 40°

C.

11. A process for sterilization of biological tissue, which process comprises treating such biological tissue at a temperature of at least about 35°

C. with an aqueous solution containing an effective amount of a lower alkanol and a concentration of at least about 25 mM of a water-soluble coupling agent that is capable of creating amide bonds and maintaining said treatment, in the presence of an effective amount of a protecting agent which complexes with either amine or carboxyl moieties and thereby deters cross-linking, for a period so as to effectively kill any bacteria and spores carried by such biological tissue, whereby contemporaneous cross-linking of the biological material can be controlled as desired.

12. The process for sterilization according to claim 11 wherein said aqueous solution contains said protecting agent at a concentration of between about 50 and about 150 mM.

13. The process for sterilization according to claim 11 wherein said protecting agent includes either a monoamine or a monocarboxylic acid.

14. The process for sterilization according to claim 11 wherein said solution contains EDC as said water-soluble coupling agent at a concentration of at least about 35 mM, wherein said treatment is carried out at between 40°

C. and about 50°

C. and wherein said treatment is carried out in the presence of at least about 50 mM of ethanolamine.

15. The process for sterilization according to claim 14 wherein said solution also contains at least about 50 mM of TRIS.

16. A process for sterilization of biological tissue material, which process comprises

treating such material with a protecting agent which is effective to complex with potentially reactive amine or carboxyl moieties on the biological tissue material so as to deter such complexed moieties from taking part in an amide-forming cross-linking reaction and thereby limit the amount of cross-linking,

treating such material with a water-soluble coupling agent capable of creating amide bonds that is effective to achieve sterilization, and

maintaining such treatment with said coupling agent for a time and at a temperature which is sufficient to achieve penetration of said coupling agent into the cells of microorganisms carried by such material and effectively kill such microorganisms.

17. The process for sterilization according to claim 16 wherein said coupling agent and said protecting agent are present in an aqueous solution being used for said treatment.

18. The process for sterilization according to claim 17 wherein said protecting agent includes hydroxyproline, lactic acid or acetic acid.

19. The process for sterilization according to claim 17 wherein said biological tissue material is pretreated with said protecting agent at a concentration of at least about 10 mM and then rinsed before treatment with an aqueous solution of said coupling agent.

20. The process for sterilization according to claim 19 wherein said protecting agent is sulfo-NHS acetate, acetic anhydride, maleic anhydride or citraconic anhydride.